Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...

Explore how low bioburden powders for terminal sterilization support sterile drug development, improve contamination control, ...

The mass production of pharmaceuticals has significantly evolved since the industrial fabrication of synthetic drugs towards the end of the 19 th century 1 with efficient developments in process ...

As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.

When looking for a contamination control strategy for your aseptic processes, consider a partner who has the expertise to answer your questions, support your project from start to finish, and then ...

As EV battery manufacturing technologies evolve, from coated film to solid-state cells, the industry is facing new contamination challenges that existing processes aren’t equipped to handle. According ...

Airborne molecular contaminants (AMCs) pose a critical challenge in semiconductor manufacturing, where even trace levels of volatile chemicals and moisture can compromise device yield and reliability.